Report Details

Report Name

Global Covid-19 Rapid Antigen Market Growth 2024-2030 Story

Pages

158

Price

$ 3660

Features

Covid-19 Rapid Antigen Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

               Abbott|||Access Bio|||BD|||Quidel|||Fujirebio|||Ellume|||OraSure Technologies|||Clip Health|||Celltrion Healthcare|||Salofa Oy|||iHealth Labs|||Novegent|||Hangzhou Alltest Biotech|||Guangzhou Decheng Biotechnology|||SD Biosensor|||MP Biomedical|||Jiangsu Well Biotech|||CTK Biotech|||Hangzhou Laihe Biotech|||Innovation Scientific|||Biohit Healthcare|||ACON Biotech|||Assure Tech|||Hangzhou Clongene Biotech|||Hangzhou Testsea Biotechnology             

Countries Covered

               United States|||Canada|||Mexico|||Brazil|||China|||Japan|||Korea|||Southeast Asia|||India|||Australia|||Germany|||France|||UK|||Italy|||Russia|||Egypt|||South Africa|||Israel|||Turkey|||GCC Countries             

Regions Covered

              Global            

Prices

Single User License:

$ 3660

Multi User License:

$ 5490

Enterprise/Corporate User License:

$ 7320